Ekso Bionics Reports Third Quarter 2022 Results
November 03, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
Quarterly Record of 33 EksoNR Bookings in Q3 2022 SAN RAFAEL, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in...
Ekso Bionics to Report Third Quarter 2022 Financial Results on November 3, 2022
October 27, 2022 08:00 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 06, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Second Quarter 2022 Results
July 28, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
July 21, 2022 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
June 13, 2022 08:00 ET
|
Ekso Bionics Holdings, Inc.
First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis RICHMOND, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...
Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer
May 26, 2022 07:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...
Ekso Bionics Reports First Quarter 2022 Results
April 28, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
April 21, 2022 08:03 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...